Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Boulardii + Bismuth Quadruple Therapy for H. Pylori Rescue Treatment
NCT07139366Phase 4Recruiting
- Sponsor
- Yongquan Shi
- Start
- Oct 2025
- Primary completion
- Sep 2026
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of saccharomyces boulardii in Helicobacter pylori infection, sponsored by Yongquan Shi. Started Oct 2025; status: recruiting.
02
Drugs
saccharomyces boulardii
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07139366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07139366.